(Q61965700)

English

Immunotherapy With Racotumomab in Advanced Lung Cancer

clinical trial

Statements

A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific Immunotherapy With Racotumomab Plus Best Support Treatment Versus Best Support Treatment in Patients With Advanced Non-small Cell Lung Camcer. (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
September 2010
0 references
September 2016
0 references
1,082
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit